LAURA HOFFMAN: Open Payments
NPI 1508498924 · CANTON, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$4,678 in 240 payments from 22 companies in 2025. Trend: 2023 $46 · 2024 $50 · 2025 $4,678
Food & beverage: $4,594Education: $84
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 68 | $1,176 |
| Janssen Biotech, Inc. | 23 | $545 |
| Daiichi Sankyo Inc. | 21 | $345 |
| Takeda Pharmaceuticals U.S.A., Inc. | 15 | $340 |
| Aimmune Therapeutics, Inc. | 16 | $320 |
| Madrigal Pharmaceuticals | 13 | $316 |
| Ipsen Biopharmaceuticals, Inc | 11 | $299 |
| Ardelyx, Inc. | 20 | $280 |
| QOL Medical, LLC | 11 | $208 |
| Phathom Pharmaceuticals, Inc. | 8 | $174 |
Products named: TREMFYA, RINVOQ, INJECTAFER, REZDIFFRA, IQIRVO, IBSRELA, ENTYVIO, Sucraid.
Industry payments across OH — which companies pay providers there.
